RADX
Radiopharm Theranostics Limited American Depositary SharesNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$34.61M
P/E Ratio
—
EPS
$-3.72
Beta
0.80
52W High
$10.63
52W Low
$3.62
50-Day MA
$4.49
200-Day MA
$5.09
Dividend Yield
—
Profit Margin
-286.20%
Forward P/E
—
PEG Ratio
—
About Radiopharm Theranostics Limited American Depositary Shares
Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company is headquartered in Carlton, Australia.
Fundamentals
| Revenue (TTM) | $16.28M |
| Gross Profit (TTM) | $-22.22M |
| EBITDA | $-39.18M |
| Operating Margin | -423.70% |
| Return on Equity | -92.10% |
| Return on Assets | -28.30% |
| Revenue/Share (TTM) | $2.10 |
| Book Value | $3.23 |
| Price-to-Book | 1.10 |
| Price-to-Sales (TTM) | 2.13 |
| EV/Revenue | 4.353 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 154.50% |
| Shares Outstanding | $7.88M |
| Float | $7.90M |
| % Insiders | 0.00% |
| % Institutions | 2.54% |
Historical Volatility
HV 10-Day
49.49%
HV 20-Day
36.81%
HV 30-Day
51.83%
HV 60-Day
51.41%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($17.20 target)
1
Strong Buy3
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026